Ratanatharathorn, V <br/><br/>
Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC).  [electronic resource] 

 -  Bone marrow transplantation  Jan 1992 
 - 49-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bone Marrow Transplantation--adverse effects<br/>Busulfan--therapeutic use<br/>Child<br/>Combined Modality Therapy<br/>Cyclophosphamide--therapeutic use<br/>Cytarabine--therapeutic use<br/>Female<br/>Graft vs Host Disease--etiology<br/>Humans<br/>Leukemia, Myeloid--drug therapy<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--drug therapy<br/>Transplantation, Homologous